Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 09:17 (602 d 12:51 ago) – Posting: # 20128
Views: 2,120

» » Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)
»
» What does your protocol say on exactly that matter?

My protocol says within (-0.20 and 0.20)

Complete thread:

Activity
 Admin contact
21,214 posts in 4,427 threads, 1,481 registered users;
online 14 (0 registered, 14 guests [including 8 identified bots]).
Forum time: Friday 21:09 CET (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5